Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes

npj Systems Biology and Applications

Volumn 1, Issue , 2015, Pages

  Steinway, Steven Nathaniel ^a   Zañudo, Jorge Gomez Tejeda ^b   Michel, Paul J ^c   Feith, David J ^c   Loughran, Thomas P ^c   Albert, Reka ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84968726686     PISSN: None     EISSN: 20567189     Source Type: Journal    
DOI: 10.1038/npjsba.2015.14     Document Type: Article

References (52)

1. Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M. & Nieto, M. A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 119, 1438-1449 (2009).
2. Nakaya, Y. & Sheng, G. Epithelial to mesenchymal transition during gastrulation: an embryological view. Dev. Growth Differ. 50, 755-766 (2008).
3. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
4. Chao, Y., Wu, Q., Acquafondata, M., Dhir, R. & Wells, A. Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron. 5, 19-28 (2012).
5. Thomson, S. et al. A systems view of epithelial-mesenchymal transition signaling states. Clin. Exp. Metastasis 28, 137-155 (2011).
6. Jordan, N. V., Johnson, G. L. & Abell, A. N. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle 10, 2865-2873 (2011).
7. Futterman, M. A., Garcia, A. J. & Zamir, E. A. Evidence for partial epithelial-tomesenchymal transition (pEMT) and recruitment of motile blastoderm edge cells during avian epiboly. Dev. Dyn. 240, 1502-1511 (2011).
8. Nieto, M. A. Epithelial plasticity: A common theme in embryonic and cancer cells. Science 342, 1234850 (2013).
9. Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580-584 (2013).
10. Zhang, J. et al. TGF-beta-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Sci. Signal. 7, ra91 (2014).
11. Tian, X. J., Zhang, H. & Xing, J. Coupled reversible and irreversible bistable switches underlying TGFbeta-induced epithelial to mesenchymal transition. Biophys. J. 105, 1079-1089 (2013).
12. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 (2004).
13. Leroy, P. & Mostov, K. E. Slug is required for cell survival during partial epithelialmesenchymal transition of HGF-induced tubulogenesis. Mol. Biol. Cell 18, 1943-1952 (2007).
14. Revenu, C. & Gilmour, D. EMT 2.0: shaping epithelia through collective migration. Curr. Opin. Genet. Dev. 19, 338-342 (2009).
15. Klymkowsky, M. W. & Savagner, P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am. J. Pathol. 174, 1588-1593 (2009).
16. Schliekelman, M. J. et al. Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. Cancer Res. 75, 1789-1800 (2015).
17. Lecharpentier, A. et al. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br. J. Cancer 105, 1338-1341 (2011).
18. Armstrong, A. J. et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol. Cancer Res. 9, 997-1007 (2011).
19. Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110-1122 (2014).
20. Lee, J. M., Dedhar, S., Kalluri, R. & Thompson, E. W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172, 973-981 (2006).
21. Steinway, S. N. et al. Network modeling of TGFbeta signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. Cancer Res. 74, 5963-5977 (2014).
22. Jou, J. & Diehl, A. M. Epithelial-mesenchymal transitions and hepatocarcinogenesis. J. Clin. Invest. 120, 1031-1034 (2010).
23. Kothari, A. N., Mi, Z., Zapf, M. & Kuo, P. C. Novel clinical therapeutics targeting the epithelial to mesenchymal transition. Clin. Transl. Med. 3, 35 (2014).
24. Altekruse, S. F., McGlynn, K. A. & Reichman, M. E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J. Clin. Oncol. 27, 1485-1491 (2009).
25. Amin, R. & Mishra, L. Liver stem cells and tgf-Beta in hepatic carcinogenesis. Gastrointest. Cancer Res. 2, S27-S30 (2008).
26. Abou-Shady, M. et al. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Am. J. Surg. 177, 209-215 (1999).
27. Sue, S. R. et al. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann. Surg. 222, 171-178 (1995).
28. Kiss, A., Wang, N. J., Xie, J. P. & Thorgeirsson, S. S. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met, TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas. Clin. Cancer Res. 3, 1059-1676 (1997).
29. Lu, M., Jolly, M. K., Levine, H., Onuchic, J. N. & Ben-Jacob, E. MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc. Natl Acad. Sci. USA 110, 18144-18149 (2013).
30. Zañudo, J. G. T. & Albert, R. Cell fate reprogramming by control of intracellular network dynamics. PLoS Comput. Biol. 11, e1004193 (2015).
31. Mani, S. A. et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl Acad. Sci. USA 104, 10069-10074 (2007).
32. Zavadil, J., Cermak, L., Soto-Nieves, N. & Bottinger, E. P. Integration of TGF-beta/ Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23, 1155-1165 (2004).
33. Kokudo, T. et al. Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J. Cell Sci. 121, 3317-3324 (2008).
34. Niimi, H., Pardali, K., Vanlandewijck, M., Heldin, C. H. & Moustakas, A. Notch signaling is necessary for epithelial growth arrest by TGF-beta. J. Cell Biol. 176, 695-707 (2007).
35. Walsh, D. W. et al. Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochim. Biophys. Acta 1782, 10-21 (2008).
36. Villanueva, A. et al. Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology 143, 1660-1669.e7 (2012).
37. Hainaud, P. et al. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Cancer Res. 66, 8501-8510 (2006).
38. Yang, Y. et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J. Clin. Invest. 121, 1373-1385 (2011).
39. Chen, K. J. et al. Reexpression of Let-7g microRNA inhibits the proliferation and migration via K-Ras/HMGA2/snail axis in hepatocellular carcinoma. Biomed. Res. Int. 2014, 742417 (2014).
40. Wang, Q., Lin, Z. Y. & Feng, X. L. Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection. World J. Gastroenterol. 7, 335-339 (2001).
41. Xu, P. et al. Differential expression of Notch family members in astrocytomas and medulloblastomas. Pathol. Oncol. Res. 15, 703-710 (2009).
42. Zhou, L. et al. The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma. PLoS ONE 8, e57382 (2013).
43. Dill, M. T. et al. Constitutive Notch2 signaling induces hepatic tumors in mice. Hepatology 57, 1607-1619 (2013).
44. Huntzicker, E. G. et al. Differential effects of targeting Notch receptors in a mouse model of liver cancer. Hepatology 61, 942-952 (2015).
45. Ding, W. et al. miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma. Oncogenesis 1, e15 (2012).
46. Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T. & Sato, J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42, 3858-3863 (1982).
47. Dor, I., Namba, M. & Sato, J. Establishment and some biological characteristics of human hepatoma cell lines. Gan 66, 385-392 (1975).
48. Saadatpour, A. & Albert, R. Boolean modeling of biological regulatory networks: a methodology tutorial. Methods 62, 3-12 (2013).
49. Zañudo, J. G. T. & Albert, R. An effective network reduction approach to find the dynamical repertoire of discrete dynamic networks. Chaos 23, 025111 (2013).
50. Kanter II & Sompolinsky, H. Associative recall of memory without errors. Phys. Rev. A 35, 380-392 (1987).
51. Shlens, J. A tutorial on principal component analysis. arXiv;arXiv:1404.1100 (2014).
52. The MathWorks I. MATLAB and Statistics Toolbox Release 2012b (Natick, MA, USA, 2012).